Phase
Condition
Stimulant Use Disorder
Treatment
Active TMS
Sham TMS
Clinical Study ID
Ages 21-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 21-65 years inclusive;
Meets DSM-5 criteria for past-year moderate or severe methamphetamine use disorder;
By Timeline Follow Back endorses at least 10 days of methamphetamine use out of thelast month;
Provides a urine drug screen positive for methamphetamine;
Able to provide informed consent;
No change in current psychiatric medication regimen, or medication free, for atleast 4 weeks prior to study entry;
Adequate English proficiency for study consent, and completion of the studyinstruments.
Exclusion
Exclusion Criteria:
Lifetime non-substance-induced psychotic disorders, schizophrenia, schizoaffectivedisorder or bipolar disorder defined by DSM-5;
Current diagnosis of DSM-5 drug use disorder other than stimulant, cannabis ornicotine use disorder;
Non-substance-induced manic episode within the past 3 years or major depressiveepisode in the past year;
Current clinically significant neurological disorder or medical illness, includinghistory of seizures, cardiovascular disease/cardiac event, which in the opinion ofthe study physician would make study participation unsafe;
Presence of a clinically significant abnormality on baseline MRI;
Inability to have an MRI;
Currently breastfeeding, is currently pregnant or lack of use of effectivecontraception in women of childbearing age, as assessed by urine pregnancy test andself-report (participants will consent to continue effective contraceptives duringthe study);
Active criminal justice involvement (i.e., any unresolved legal problems that couldjeopardize continuation or completion of the study);
History of head injury with loss of consciousness for more than 15 minutes;
Diagnosis of dementia;
Prescribed benzodiazepines or anticonvulsants;
Currently enrolled in formal substance use disorder treatment;
Metal implants or non-removable metal objects above the waist;
Lifetime history of prior clinical treatment with TMS;
Serious risk of suicide or homicide;
Unable/unwilling to follow the study procedures;
History of intractable migraine;
Assessed to be at risk for alcohol or opioid withdrawal.
Study Design
Study Description
Connect with a study center
University of Colorado Anschutz Medical Campus
Aurora, Colorado 80045
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.